Ebola Vaccines and Antivirals: What Lies Ahead?

December 15, 2014

WASHINGTON, December 15, 2014- The Center for Strategic and International Studies (CSIS) Global Health Policy Center will host a discussion on the current efforts of industry, governments, NGOs, international organizations, and foundations to facilitate production of Ebola vaccines and antivirals.  Full details appear below. 

WHEN/WHERE:
Tuesday, December 16, 2014
3:00 PM - 5:00 PM
Second Floor Conference Room
CSIS, 1616 Rhode Island Avenue, NW
Washington, DC 20036

Credentialed members of the press who wish to attend should email aschwartz@csis.org or click below. 

Featuring:

Dr. Anthony Fauci
Director of the National Institute of Allergy and Infectious Disease (NIAID)

Dr. Moncef Slaoui
Member of the GSK Board of Directors and the Corporate Executive Team

Dr. Johan Van Hoof
Global Therapeutic Area Head, Infectious Diseases and Vaccines, Janssen Research & Development, LLC

Dr. Rohit Malpani
Director of Policy and Analysis, Medecins Sans Frontieres Access Campaign

Dr. Julie Gerberding
President, Merck Vaccines

Moderated by:

Dr. J. Stephen Morrison 
Senior Vice President and Director of the CSIS Global Health Policy Center 

###

The Center for Strategic and International Studies (CSIS) is a bipartisan, non-profit organization founded in 1962 and headquartered in Washington, D.C. It seeks to advance global security and prosperity by providing strategic insights and policy solutions to decision makers.